Arrowstreet Capital Limited Partnership Acquires 835,464 Shares of Express Scripts Holding (ESRX)

Arrowstreet Capital Limited Partnership increased its position in shares of Express Scripts Holding (NASDAQ:ESRX) by 31.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,450,844 shares of the company’s stock after buying an additional 835,464 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Express Scripts were worth $257,571,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of ESRX. SeaCrest Wealth Management LLC acquired a new position in Express Scripts during the fourth quarter worth $105,000. Bank of Nova Scotia Trust Co. acquired a new position in Express Scripts during the third quarter worth $120,000. Monroe Bank & Trust MI increased its holdings in Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock worth $156,000 after buying an additional 970 shares during the last quarter. Harvest Fund Management Co. Ltd acquired a new position in Express Scripts during the fourth quarter worth $183,000. Finally, Nelson Roberts Investment Advisors LLC acquired a new position in Express Scripts during the third quarter worth $193,000. Institutional investors and hedge funds own 87.46% of the company’s stock.

A number of brokerages recently weighed in on ESRX. Zacks Investment Research upgraded shares of Express Scripts from a “hold” rating to a “buy” rating and set a $82.00 target price on the stock in a report on Wednesday, February 14th. BidaskClub downgraded shares of Express Scripts from a “buy” rating to a “hold” rating in a report on Wednesday, February 14th. Royal Bank of Canada upgraded shares of Express Scripts from a “sector perform” rating to an “outperform” rating and set a $68.00 target price on the stock in a report on Wednesday, January 31st. Robert W. Baird boosted their target price on shares of Express Scripts from $57.00 to $59.00 and gave the stock a “neutral” rating in a report on Wednesday, October 25th. Finally, SunTrust Banks set a $82.00 target price on shares of Express Scripts and gave the stock a “buy” rating in a report on Thursday, December 14th. Five research analysts have rated the stock with a sell rating, eight have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $78.93.

In other news, VP Glen D. Stettin sold 3,449 shares of the business’s stock in a transaction dated Thursday, January 11th. The shares were sold at an average price of $81.00, for a total value of $279,369.00. Following the completion of the sale, the vice president now owns 33,715 shares of the company’s stock, valued at $2,730,915. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Glen D. Stettin sold 3,448 shares of the business’s stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total transaction of $262,048.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 17,001 shares of company stock valued at $1,249,505. Company insiders own 0.68% of the company’s stock.

Express Scripts Holding (ESRX) opened at $75.23 on Monday. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. Express Scripts Holding has a 52-week low of $55.80 and a 52-week high of $83.49. The company has a market cap of $42,610.00, a price-to-earnings ratio of 12.50, a price-to-earnings-growth ratio of 0.81 and a beta of 0.93.

Express Scripts announced that its Board of Directors has initiated a share buyback plan on Monday, December 18th that allows the company to repurchase 45,000,000 shares. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company’s board believes its stock is undervalued.

COPYRIGHT VIOLATION NOTICE: “Arrowstreet Capital Limited Partnership Acquires 835,464 Shares of Express Scripts Holding (ESRX)” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another publication, it was stolen and reposted in violation of United States & international copyright laws. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/19/arrowstreet-capital-limited-partnership-acquires-835464-shares-of-express-scripts-holding-esrx-2.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply